Medtronic (MDT) ebitda was $10.3B in FY2026 (+7% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2026
$10.3B
+7%
2025
$9.5B
+11%
2024
$8.6B
-7%
2023
$9.2B
+0%
2022
$9.2B
+13%
2021
$8.1B
-2%
2020
$8.2B
-11%
2019
$9.2B
-4%
2018
$9.6B
+11%
2017
$8.6B
+1%
2016
$8.6B
+55%
2015
$5.5B
+15%
2014
$4.8B
-11%
2013
$5.4B
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$2.7B
Q1 2026
$3.7B
Q3 2025
$2.2B
Q2 2025
$2.3B
Q1 2025
$3.5B
Q3 2024
$2.1B
Q2 2024
$2.1B
Q1 2024
$2.6B
Q3 2023
$2.0B
Q2 2023
$2.1B
Q1 2023
$3.1B
Q3 2022
$2.1B
Source: MDT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.